The present invention relates to new polynucleotides derived from the nucleotide sequence of the IFN.alpha.-7 gene comprising new SNPs, and new polypeptides derived from the wild-type IFN.alpha.-7 protein comprising at least one mutation caused by at least one SNP of the invention as well as their therapeutic uses.

 
Web www.patentalert.com

< System and method for displaying a health status of hospitalized patients

> Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
~ 00447